EMAIL THIS PAGE TO A FRIEND

American journal of physiology. Heart and circulatory physiology

Distribution volumes of macromolecules in human ovarian and endometrial cancers--effects of extracellular matrix structure.


PMID 25380817

Abstract

Elements of the extracellular matrix (ECM), notably collagen and glucosaminoglycans, will restrict part of the space available for soluble macromolecules simply because the molecules cannot occupy the same space. This phenomenon may influence macromolecular drug uptake. To study the influence of steric and charge effects of the ECM on the distribution volumes of macromolecules in human healthy and malignant gynecologic tissues we used as probes 15 abundant plasma proteins quantified by high-resolution mass spectrometry. The available distribution volume (VA) of albumin was increased in ovarian carcinoma compared with healthy ovarian tissue. Furthermore, VA of plasma proteins between 40 and 190 kDa decreased with size for endometrial carcinoma and healthy ovarian tissue, but was independent of molecular weight for the ovarian carcinomas. An effect of charge on distribution volume was only found in healthy ovaries, which had lower hydration and high collagen content, indicating that a condensed interstitium increases the influence of negative charges. A number of earlier suggested biomarker candidates were detected in increased amounts in malignant tissue, e.g., stathmin and spindlin-1, showing that interstitial fluid, even when unfractionated, can be a valuable source for tissue-specific proteins. We demonstrate that the distribution of abundant plasma proteins in the interstitium can be elucidated by mass spectrometry methods and depends markedly on hydration and ECM structure. Our data can be used in modeling of drug uptake, and give indications on ECM components to be targeted to increase the uptake of macromolecular substances.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

C7806 Collagen from bovine nasal septum, Bornstein and Traub Type II, powder
C1188 Collagen from bovine tracheal cartilage, Bornstein and Traub Type II, powder
C3511 Collagen from calf skin, Bornstein and Traub Type I (Sigma Type III), solid
C0543 Collagen from Engelbreth-Holm-Swarm murine sarcoma basement membrane, Type IV (Miller), lyophilized powder (from 0.2 μm-filtered solution), BioReagent, suitable for cell culture
C4407 Collagen from human placenta, Bornstein and Traub Type III (Sigma Type X), powder
C7774 Collagen from human placenta, Bornstein and Traub Type I (Sigma Type VIII), powder
C3657 Collagen from human placenta, Bornstein and Traub Type V (Sigma Type IX), powder
C8374
Collagen from human placenta, Bornstein and Traub Type IV, powder
H4417 Collagen from human placenta, Bornstein and Traub Type IV, solution, suitable for cell culture, ≥95% (SDS-PAGE)
C5608 Collagen from rabbit skin, Bornstein and Traub Type I, powder
C6745 Collagen Type IV from human cell culture, Bornstein and Traub Type IV, 0.3 mg/mL, sterile-filtered, BioReagent, suitable for cell culture
H7630
Hyaluronic acid sodium salt from bovine vitreous humor
H5388
Hyaluronic acid sodium salt from rooster comb, avian glycosaminoglycan polysaccharide
53747
Hyaluronic acid sodium salt from Streptococcus equi, bacterial glycosaminoglycan polysaccharide
49775
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 1,200
40583
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 8,000-15,000
94137
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 10,000-30,000
97616
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 15,000-30,000
42686
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 30,000-50,000
08185
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 50,000-70,000
75048
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 70,000-90,000
96144
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 70,000-120,000
75046
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 90,000-110,000
06742
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 120,000-350,000
75043
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 130,000-150,000
75044
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 150,000-300,000
00941
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 300,000-500,000
75574
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 500,000-750,000
53163
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 750,000-1,000,000
41897
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 1,000,000-1,250,000